⌘K

Login Start Free

Home/Filings/4/0001204459-09-002366

4//SEC Filing

Morgan Henry 4

Accession 0001204459-09-002366

CIK 0000875622other

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 6:19 PM ET

Size

12.8 KB

Accession

0001204459-09-002366

Insider Transaction Report

Form 4

Period: 2009-12-11

BIOSPECIFICS TECHNOLOGIES CORPBSTC

Director

Transactions

Sale
Common Stock
2009-12-11$30.04/sh−11,254$338,090→ 32,274 total
Exercise/Conversion
Stock Option (Right to Buy)
2009-12-11−10,000→ 164,425 total
Exercise: $1.00From: 2002-04-19Exp: 2011-04-18→ Common Stock, $.001 par value (10,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2009-12-11−10,000→ 174,425 total
Exercise: $2.56From: 2005-06-05Exp: 2010-06-04→ Common Stock, $.001 par value (10,000 underlying)
Exercise/Conversion
Common Stock
2009-12-11$2.56/sh+10,000$25,630→ 33,528 total
Exercise/Conversion
Common Stock
2009-12-11$1.00/sh+10,000$10,000→ 43,528 total
Sale
Common Stock
2009-12-14$30.36/sh−200$6,071→ 32,074 total

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1

filerCIK 0001375327

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 6:19 PM ET
Size: 12.8 KB

View on SEC.gov